Neoadjuvant therapy group :None

2 trials

Sponsors

Department of Anesthesiology, Affiliated Cancer Hospital of Nanjing Medical University, Affiliated Cancer Hospital of Nanjing Medical University

Conditions

Esophageal Cancer

Unknown Phase

The Impact of Neoadjuvant Therapy on the Intraoperative Remifentanil Dosage in Esophageal Cancer Patients: A Prospective Observational Study Based on the IoC

Active, not recruitingChiCTR2500105958

Department of Anesthesiology, Affiliated Cancer Hospital of Nanjing Medical UniversityEsophageal Cancer

Start: 2025-07-15Updated: 2025-07-21

The impact of neoadjuvant therapy on the Pharmacodynamics of Rocuronium Bromide in elderly patients with esophageal cancer.

Active, not recruitingChiCTR2500106541

Affiliated Cancer Hospital of Nanjing Medical UniversityEsophageal Cancer

Start: 2025-08-01Updated: 2025-08-18

Related Papers

Protocol for a cohort study: evaluating the effect of neoadjuvant immunochemotherapy on intraoperative remifentanil consumption during IoC2-guided anesthesia in elderly patients with esophageal cancer

Figshare2026-07-29

Protocol for a cohort study: evaluating the effect of neoadjuvant immunochemotherapy on intraoperative remifentanil consumption during IoC2-guided anesthesia in elderly patients with esophageal cancer

Figshare2026-07-29

Protocol for a cohort study: evaluating the effect of neoadjuvant immunochemotherapy on intraoperative remifentanil consumption during IoC2-guided anesthesia in elderly patients with esophageal cancer.

2026-07-29